BioSante reports good results from phase II AML vaccine study

Submitted by Ross Bonander Wed 03/24/2010

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

BioSante Pharmaceuticals is reporting positive results from a Phase II study investigating their GVAX Vaccine for acute myeloid leukemia. The company also learned that the FDA has granted GVAX Orphan Drug Status.

In the Phase II study, published in Blood, 85% of patients achieved a complete response to the therapy, which included the vaccine, immunotherapy-primed lymphocytes and an autologous stem cell transplantation.

BioSante is slowly building up a portfolio of cancer drugs: the company's GVAX Pancreas Vaccine was recently given Orphan Drug Status, and it currently has a 'vaccine' in clinical trials for breast cancer.

With few exceptions, true cancer vaccines have proven elusive for researchers, as they are unable to rouse a response from the immune system to attack the body's cancerous cells because those cells manage to escape detection.

By Ross Bonander

Source: BioSante

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.